Research graph
References from Re: Mandel P, Wenzel M, Chun F, et al. Role of Local Treatment to the Prostate in Patients with De Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors. Eur Urol Open Sci 2026;87:16–24. Local targets link to admitted publications; unresolved targets remain external evidence.
Role of local treatment to the prostate in patients with de novo low-volume metastatic hormone-sensitive prostate cancer receiving androgen receptor pathway inhibitors
10.1016/j.euros.2026.03.010 · 2026 · External reference
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
10.1016/s0140-6736(18)32486-3 · 2018 · External reference
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
10.1016/s0140-6736(24)01865-8 · 2024 · External reference
Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial
10.1200/jco.2017.75.3657 · 2018 · External reference
Combination of androgen deprivation therapy with radical local therapy versus androgen deprivation therapy alone for newly diagnosed oligometastatic prostate cancer: a phase II randomized controlled trial
10.1016/j.euo.2022.06.001 · 2022 · External reference
